These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28443616)

  • 1. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
    Rabin RA; Barr MS; Goodman MS; Herman Y; Zakzanis KK; Kish SJ; Kiang M; Remington G; George TP
    Neuropsychopharmacology; 2017 Oct; 42(11):2259-2271. PubMed ID: 28443616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; George TP
    Schizophr Res; 2018 Apr; 194():55-61. PubMed ID: 28285022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; Stefan C; Budney AJ; George TP
    Schizophr Res; 2018 Apr; 194():47-54. PubMed ID: 28506704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
    Bonnet U; Borda T; Scherbaum N; Specka M
    Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning of long-term heavy cannabis users seeking treatment.
    Solowij N; Stephens RS; Roffman RA; Babor T; Kadden R; Miller M; Christiansen K; McRee B; Vendetti J;
    JAMA; 2002 Mar; 287(9):1123-31. PubMed ID: 11879109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
    Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence.
    Rabin RA; Dermody SS; George TP
    Drug Alcohol Depend; 2018 Apr; 185():181-188. PubMed ID: 29459327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence.
    Hanson KL; Winward JL; Schweinsburg AD; Medina KL; Brown SA; Tapert SF
    Addict Behav; 2010 Nov; 35(11):970-6. PubMed ID: 20621421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.
    Rentzsch J; Stadtmann A; Montag C; Kunte H; Plöckl D; Hellweg R; Gallinat J; Kronenberg G; Jockers-Scherübl MC
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):409-21. PubMed ID: 26182894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.
    Sánchez-Torres AM; Basterra V; Rosa A; Fañanás L; Zarzuela A; Ibáñez B; Peralta V; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):643-53. PubMed ID: 23580110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabis use status on cognitive function, in males with schizophrenia.
    Rabin RA; Zakzanis KK; Daskalakis ZJ; George TP
    Psychiatry Res; 2013 Apr; 206(2-3):158-65. PubMed ID: 23246245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory.
    Schuster RM; Gilman J; Schoenfeld D; Evenden J; Hareli M; Ulysse C; Nip E; Hanly A; Zhang H; Evins AE
    J Clin Psychiatry; 2018 Oct; 79(6):. PubMed ID: 30408351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.
    Rabin RA; Zakzanis KK; George TP
    Schizophr Res; 2011 May; 128(1-3):111-6. PubMed ID: 21420282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
    Boggs DL; Surti TS; Esterlis I; Pittman B; Cosgrove K; Sewell RA; Ranganathan M; D'Souza DC
    Schizophr Res; 2018 Apr; 194():62-69. PubMed ID: 28392208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cannabis in cognitive functioning of patients with schizophrenia.
    Schnell T; Koethe D; Daumann J; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2009 Jul; 205(1):45-52. PubMed ID: 19326102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia.
    Núñez LA; Gurpegui M
    Acta Psychiatr Scand; 2002 Mar; 105(3):173-8. PubMed ID: 11939970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-taking in schizophrenia and controls with and without cannabis dependence.
    Fischer BA; McMahon RP; Kelly DL; Wehring HJ; Meyer WA; Feldman S; Carpenter WT; Gorelick DA
    Schizophr Res; 2015 Feb; 161(2-3):471-7. PubMed ID: 25467541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.